BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025)
BridgeBio Pharma (BBIO) reported Tax Rate of 0.08% for Q4 2025, up 52.0% on a YoY basis from 0.06% in Q4 2024, and down 89.77% sequentially from 0.83% in Q3 2025.
BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025) Analysis & Trends
BridgeBio Pharma (BBIO) has 2 years of Tax Rate data on file, last reported at 0.08% in Q4 2025.
- For the quarter ending Q4 2025, Tax Rate rose 52.0% year-over-year to 0.08%; the trailing twelve-month figure through Dec 2025 stood at 0.23% (changed N/A YoY), and the FY2025 full-year result was 0.06%, up 15.0% from the prior year.
- Tax Rate fell to 0.08% in Q4 2025, from 0.83% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.83% in Q3 2025 to a low of 1.16% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.08% |
| Dec 31, 2025 | 0.08% |
| Dec 31, 2025 | 0.08% |
| Sep 30, 2025 | 0.83% |
| Sep 30, 2025 | 0.83% |
| Sep 30, 2025 | 0.83% |
| Jun 30, 2025 | -1.16% |
| Jun 30, 2025 | -1.16% |
| Jun 30, 2025 | -1.16% |
| Dec 31, 2024 | -0.43% |
| Dec 31, 2024 | -0.43% |
| Dec 31, 2024 | -0.43% |